Literature DB >> 10790218

Analysis of the human KCNH2(HERG) gene: identification and characterization of a novel mutation Y667X associated with long QT syndrome and a non-pathological 9 bp insertion.

A Paulussen1, P Yang, M Pangalos, P Verhasselt, R Marrannes, C Verfaille, I Vandenberk, R Crabbe, F Konings, W Luyten, M Armstrong.   

Abstract

Long QT (LQT) syndrome is a potentially life-threatening disorder, characterized by a distinct cardiac arrhythmia known as torsades de pointes. Mutations within a number of genes linked to the familial form, including that coding for a cardiac potassium channel called KCNH2 (HERG), have been described based on the characterized genomic organization. A standardized method was developed to screen the entire gene for gene variants. We report a single base pair substitution, introducing a premature STOP codon at codon 667 of the gene in a healthy individual with an extended QTc interval (460 msec). In vitro expression of the codon Y667X variant in Xenopus oocyte suggests that the autosomal dominant variant does not function in a dominant/negative manner and cannot co-assemble to form a channel, resulting in a reduction of the KCNH2 current, and an extension of the QT interval. This indicates that pathogenic LQT gene variants exist in the apparently normal population, the prognosis and clinical consequences of which remain to be determined. The assays described should facilitate future studies into this area. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790218     DOI: 10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU18>3.0.CO;2-T

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome.

Authors:  Qiuming Gong; Li Zhang; G Michael Vincent; Benjamin D Horne; Zhengfeng Zhou
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

2.  Clinical and electrophysiological characterization of a novel mutation R863X in HERG C-terminus associated with long QT syndrome.

Authors:  Siyong Teng; Lijuan Ma; Yingxue Dong; Chunxia Lin; Jue Ye; Robert Bähring; Vitya Vardanyan; Yanzong Yang; Zhihu Lin; Olaf Pongs; Rutai Hui
Journal:  J Mol Med (Berl)       Date:  2004-01-09       Impact factor: 4.599

Review 3.  Role of microRNAs in diabetes.

Authors:  Xiaoqing Tang; Guiliang Tang; Sabire Ozcan
Journal:  Biochim Biophys Acta       Date:  2008-07-04

Review 4.  MicroRNAs as a therapeutic target for cardiovascular diseases.

Authors:  Paras Kumar Mishra; Neetu Tyagi; Munish Kumar; Suresh C Tyagi
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

5.  Association of the hERG mutation with long-QT syndrome type 2, syncope and epilepsy.

Authors:  Guoliang Li; Rui Shi; Jine Wu; Wenqi Han; Aifeng Zhang; Gong Cheng; Xiaolin Xue; Chaofeng Sun
Journal:  Mol Med Rep       Date:  2016-02-04       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.